Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas S Lin

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Current Opinion in Oncology|October 2, 2007
Flavopiridol in the treatment of chronic lymphocytic leukemiaBeth A Christian, Michael R Grever, John C Byrd, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2015
Observational Retrospective Study of Altered Biodistribution of Tositumomab and 131I-TositumomabRichard L Wahl, Thierry J Horner, Thomas S Lin, et al.
Leukemia & Lymphoma|August 3, 2002
Seventy-two hour continuous infusion flavopiridol in relapsed and refractory mantle cell lymphomaThomas S Lin, Orion M Howard, Donna S Neuberg, et al.
Transplantation|July 23, 2002
Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantationThomas S Lin, David Zahrieh, Edie Weller, et al.
European Journal of Haematology|September 9, 2008
High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphomaMehdi Hamadani, Don M Benson, Thomas S Lin, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 3, 2016
CHOP Chemotherapy Followed by Tositumomab and Iodine-131 Tositumomab for Previously Untreated Diffuse Large B-cell LymphomaJohn P Leonard, Stephanie A Gregory, Hedy Smith, et al.
Hematology/Oncology Clinics of North America|August 25, 2004
Antibody therapy for chronic lymphocytic leukemia: a promising new modalityThomas S Lin, Mollie Moran, Margaret Lucas, et al.
Leukemia Research|October 31, 2006
High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myelomaDon M Benson, Patrick J Elder, Thomas S Lin, et al.
Leukemia & Lymphoma|October 25, 2008
Feasibility of allogeneic hematopoietic stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphomaMehdi Hamadani, Farrukh T Awan, Patrick Elder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2007
Computed tomography scans do not improve the predictive power of 1996 national cancer institute sponsored working group chronic lymphocytic leukemia response criteriaKristie A Blum, Donn Young, Sarah Broering, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Current Opinion in Oncology|October 2, 2007
Flavopiridol in the treatment of chronic lymphocytic leukemiaBeth A Christian, Michael R Grever, John C Byrd, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2015
Observational Retrospective Study of Altered Biodistribution of Tositumomab and 131I-TositumomabRichard L Wahl, Thierry J Horner, Thomas S Lin, et al.
Leukemia & Lymphoma|August 3, 2002
Seventy-two hour continuous infusion flavopiridol in relapsed and refractory mantle cell lymphomaThomas S Lin, Orion M Howard, Donna S Neuberg, et al.
Transplantation|July 23, 2002
Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantationThomas S Lin, David Zahrieh, Edie Weller, et al.
European Journal of Haematology|September 9, 2008
High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphomaMehdi Hamadani, Don M Benson, Thomas S Lin, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 3, 2016
CHOP Chemotherapy Followed by Tositumomab and Iodine-131 Tositumomab for Previously Untreated Diffuse Large B-cell LymphomaJohn P Leonard, Stephanie A Gregory, Hedy Smith, et al.
Hematology/Oncology Clinics of North America|August 25, 2004
Antibody therapy for chronic lymphocytic leukemia: a promising new modalityThomas S Lin, Mollie Moran, Margaret Lucas, et al.
Leukemia Research|October 31, 2006
High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myelomaDon M Benson, Patrick J Elder, Thomas S Lin, et al.
Leukemia & Lymphoma|October 25, 2008
Feasibility of allogeneic hematopoietic stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphomaMehdi Hamadani, Farrukh T Awan, Patrick Elder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2007
Computed tomography scans do not improve the predictive power of 1996 national cancer institute sponsored working group chronic lymphocytic leukemia response criteriaKristie A Blum, Donn Young, Sarah Broering, et al.
Pageof 8